【黃斑部】《Character Bio》完成9,300萬美元B輪，首推「老年黃斑部病變(AMD)」臨床

 【黃斑部】《Character Bio》完成9,300萬美元B輪，首推「老年黃斑部病變(AMD)」藥物臨床試驗

 文章出處  

Businesswire 

 

 原文標題  

Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases 

 

 Twitter  

https://x.com/aimedadviser/status/1904703430406660243 

 

 文章序號  

7621 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.